“Humanitarianism in the Modern World. The moral economy of famine relief” published by Cambridge University Press, is an open access book written by a team of three people, whose aim is to provide a history of contemporary humanitarianism through the prism of famines. Norbert Götz, Georgina Brewis and Steffen Werther are treading on fertile ground, as the number of publications on the history of humanitarianism has multiplied in recent years. However, the contribution they present here is rich and original.

Myfanwy James is a research fellow at the London School of Hygiene and Tropical Medicine & DPhil (PhD) graduate from the University of Oxford. In this video, she presents her thesis entitled: “Instruments of Identity: Médecins Sans Frontières and Humanitarian Negotiations for Access in the Democratic Republic of the Congo (RDC)”. 

We can all agree that the emergence of Covid-19 vaccine is “an absolutely astonishing development”, but vaccines are unlikely to completely halt the spread of the virus, let alone eradicate it. Yet even without achieving herd immunity, the ability to vaccinate vulnerable people seems to be reducing hospitalizations and deaths from Covid-19. 

There is a new book out by Patrick de Saint-Exupéry entitled La traversée. Une odyssée au cœur de l’Afrique [The crossing. An odyssey in the heart of Africa]. What odyssey? Crossing the Congo (Zaire, later the Democratic Republic of Congo) from Rwanda. The author describes his encounters, the beers he had here and there, the bumpy rides on the back of a motorcycle (to Kisangani), a trip down the Congo River, flying over the dense forest on his way to Mbandaka.

Within four months of the first notification of Ebola cases in August 2018, the Nord Kivu (and Ituri) Ebola epidemic had become the second-largest on record. Notwithstanding a rapid and massive mobilisation of resources, the outbreak continued beyond the most pessimistic predictions and the case fatality rate (the proportion of people with the infection who die from it) remained static at 66%. Despite numerous lesson-learning exercises following the Ebola epidemic in West Africa in 2014–2016, and despite the development of new vaccines and treatments, after 3,444 cases and 2,264 deaths it is difficult to claim that outcomes are better this time around.